G2B’s Founders

Meritxell Teixidó, PhD
CEO & CSO
Chief Executive & Scientific Officer

With more than 10 years of experience in the field of brain drug delivery.
  • Peptide chemistry
  • Drug delivery technologies
  • Blood-brain barrier transport studies
  • Leadership of high-performance teams
  • Executive management

Gloria Sanclimens, PhD
COO
Chief Operating Officer

With more than 18 years of experience in pharma industry.
  • R&D and innovation expert
  • Drug substance and Drug product development of NCE, VAM, Generic, OTC, Food supplements and Cosmetics products
  • CMC development for several EU countries, US, LATAM, Russia and Japan
  • In-licensing and project management

Esther Riambau, BSc, MBA
BDA
Business Development Advisor

With more than 18 years of experience in business development.
  • Fundraising
  • Business development
  • Licensing-out
  • Technology-based entrepreneurship
  • Strategic planning
  • Business modeling

Team

Andres Morales 
CMO, Chief Medical Officer

Alejandro Sosnik, Prof.
Nanotech Advisor
Prof. of Materials Science & Engineering at
Technion – Israel Institute of Technology

Sergi González
CFO, Chief Financial Officer

Carles Taulé
BDM, Business Development Manager

Helena Castillo, PhD
Preclinical & Clinical Project Manager

Inma Alavedra
CCS, Corporate Communication Specialist

Patil Bhalchandra
GMP Consultant & Quality Auditor
(based in Mumbai)

Marina Plaza, PhD
Chemist Research Scientist

Clàudia Resa
Doctoral Industrial PhD Student

External
Advisory
Committee

Pablo Magnani
COO at TOWA Pharma International

Andrés G. Fernández, PhD
Biopharma Industry Expert

Elena Canetti
Life Science Strategy Advisor

Ernest Giralt, Prof.
Emeritus Professor at the Institute for Research in Biomedicine (IRB Barcelona)  and at the University of Barcelona

Fernando Albericio, Prof.
Professor at the University of KwaZulu-Natal and the University of Barcelona

Gloria García
Head of Fundraising, Hospital Sant Joan de Déu, Barcelona

Ricard Casanovas
Pediatric Patients and Families Advocate

Dr. Dirk Groenewegen
EIC Coach

Values

Gate2Brain will promote important core values within the team:

  • 1

    Cooperation

    Belief in the power of partnership at all levels, both internally and with institutions, colleagues, patients’ associations and other stakeholders around the world.

  • 2

    Commitment

    Pursuit of continuous improvement of our products and activities and to provide true and consistent value.

  • 3

    Courage

    Readiness to pursue innovation and creativity and its application to patients, always striving to overcome the challenges and bring about the change we want to see in the world.

  • 4

    Passion

    Finding joy in every task and being continuously focused on improvement. Meeting our challenges with creativity and enthusiasm as a team.

Gate2Brain thanks
the support of:

 

The contract is part of the grant PTQ2022-012493 financed by the MCIU/AEI/10.13039/501100011033

 

Gate2Brain SL has been the beneficiary of a project subsidized by the CDTI with the collaboration of the Ministry of Science and Innovation and co-financed by the European Union – Next Generation EU. File number SNEO-20211130.

 

Company Seals:

Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social